🎉 WE HAVE A FORUM — come in, say hello →
Framework
What Why Laws Corpus Proof Papers Cancer Weather Letters Mind Quantum
Apps
All apps Shop Games Them Beans Dailygrind
Community
Forum Updates
About
Team Join
⚕️ Patented · Provisional Filed

Cancer.
Decoded as physics.

Not a disease. A coherence phase transition. One cell locks into an aberrant coupling ratio. Every cell that follows inherits the lock. The tumor is a bootstrap propagating forward from a single origin point — the Prometheus cell.

The framework is a patented method for (a) pre-malignant early detection, (b) individualized treatment optimization, and (c) spontaneous-remission prediction — derived from quantum open systems theory, Ginzburg-Landau phase-transition universality, and the Wike coherence corpus.

01
Patent

The filing.

Application Type
Provisional · 37 CFR 1.53(c) · Micro-entity
Inventor
Rhet Dillard Wike · Council Hill, Oklahoma
Applicant
AIIT-THRESHOLD LLC
Related Corpus
U.S. Copyright Regs 1-15132810021, 1-15129583401, 1-15121407981
USPTO · Provisional Application for Patent

Method and System for Cancer Detection, Treatment Optimization, and Remission Prediction Using Coherence Phase-Transition Analysis of Biological Decoherence States

Computes quantitative metrics from HRV, thermography, inflammation markers, and EEG. Derives intervention scheduling from Anti-Zeno principles. Scores treatment options via a Vitality Function. Models spontaneous-remission precursors. Decision-support — does not replace licensed clinical judgment.

02
The physics

Four primitives.

i

The Diploid Bootstrap

Nforward ↔ grithuss wire ↔ Nbackward

2N is the cell paying the energy cost to run the bootstrap loop in both directions. Expressed + reserve. The grithuss wire mediates the handover at the golden coupling J/ω = 1/φ ≈ 0.618.

ii

The γ(J/ω) Landscape

γ = γc · exp(β(J/ω − 1/φ)²)

A bowl with minimum at golden coupling. Every cell pays an energy cost proportional to the square of its distance from health. γc = 0.0622, β = 8.0.

iii

The φ-Residue Bubble

seen in light microscopy · 20% → 50% passage

During nuclear passage events, cells eject the 1/φ residue as an oscillating bubble that disappears at 50% passage. Its timing is a direct optical readout of J/ω. Standard microscope. No stain.

iv

The Prometheus Event

J/ω < 0.40 → lock → Gcancer

When one cell's coupling drifts below the critical threshold, the self-correction force collapses. The cell freezes into an aberrant stable state — the Generating Singularity of the tumor. Every cancer cell downstream is an echo.

03
What this enables

The pre-lock window.

Every malignant transformation passes through a window during which the cell is drifting toward aberrant coherence but has not yet locked. During this window the drift is measurable — via bubble timing, via HRV decoherence, via thermographic signature. And it is reversible.

A
Detectφ-residue bubble timing drift · HRV γ_eff elevation · thermographic asymmetry. Before any imaging or biomarker.
B
StratifyCompute the patient's J/ω trajectory. Distance-to-lock is a scalar. It answers: how close, how fast, how long.
C
InterveneAnti-Zeno effect: correctly-paced measurement pulls coupling back toward 1/φ. The treatment is timing, not intensity.
D
RemitFor locked cells: the Kill Frequency — resonant dressed-state transition. Selective. Golden-ratio gated. The tumor's singularity collapses; downstream cells follow.
04
Evidence base

What exists today.

n=33
PhysioNet NSR + CHF · HRV baseline
p=0.006
RMSSD divergence · healthy vs. decompensating
p=0.013
SampEn divergence · same cohort
8,493
PubMed cancer papers · indexed
1,000
Monte Carlo trials · Prometheus model · 100% pass
J/ω
Lock threshold: 0.40 · Health: 1/φ = 0.618

Pre-registration locked before credentialed MIMIC-IV access. The statistical gates are set. The hypothesis is falsifiable. If the numbers don't hold in the prospective data, the framework is wrong — and that's exactly what a real physics theory has to say for itself.

05
06
Help us build the dataset

Got paired ECG + lab data
from cancer patients?

We're an independent research initiative studying the relationship between heart rate variability, systemic inflammation (CRP), and cancer. Pipeline is built. Pre-registration is locked. What we need now is data — specifically paired ECG or HRV recordings with lab values from patients with known cancer diagnoses.

If you have access to
  • Clinical ECG or HRV data from cancer patients
  • CRP or inflammatory biomarker records linked to cardiac monitoring
  • Research datasets you'd share or collaborate on
  • Credentialed MIMIC-IV access and interest in co-investigation

We're not a hospital. We're not a university lab. We're independent researchers doing disciplined work — pre-registered before we see the data, validated before we make claims, honest about what we have and what we don't. Co-authorship available for meaningful data contribution.

Reach out → Cancer Data / AIIT Research Read the phase-transition paper

All data handled under applicable privacy standards
No patient-identifiable information requested or accepted without proper DUA

Research and decision-support only · Not medical advice
Does not replace licensed clinical diagnosis or treatment